Multilevel analyses of on-demand medication data, with an application to the treatment of Female Sexual Interest/Arousal Disorder

被引:3
|
作者
Kessels, Rob [1 ]
Bloemers, Jos [1 ,2 ,3 ]
Tuiten, Adriaan [1 ]
van der Heijden, Peter G. M. [4 ,5 ]
机构
[1] Emot Brain BV, Almere, Flevoland, Netherlands
[2] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
[3] Univ Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands
[4] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands
[5] Univ Southampton, Dept Social Sci, Southampton, Hants, England
来源
PLOS ONE | 2019年 / 14卷 / 08期
关键词
REFLUX SYMPTOMS; EFFICACY; MODELS; AROUSAL; SAFETY;
D O I
10.1371/journal.pone.0221063
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data from clinical trials investigating on-demand medication often consist of an intentionally varying number of measurements per patient. These measurements are often observations of discrete events of when the medication was taken, including for example data on symptom severity. In addition to the varying number of observations between patients, the data have another important feature: they are characterized by a hierarchical structure in which the events are nested within patients. Traditionally, the observed events of patients are aggregated into means and subsequently analyzed using, for example, a repeated measures ANOVA. This procedure has drawbacks. One drawback is that these patient means have different standard errors, first, because the variance of the underlying events differs between patients and second, because the number of events per patient differs. In this paper, we argue that such data should be analyzed by applying a multilevel analysis using the individual observed events as separate nested observations. Such a multilevel approach handles this drawback and it also enables the examination of varying drug effects across patients by estimating random effects. We show how multilevel analyses can be applied to on-demand medication data from a clinical trial investigating the efficacy of a drug for women with low sexual desire. We also explore linear and quadratic time effects that can only be performed when the individual events are considered as separate observations and we discuss several important statistical topics relevant for multilevel modeling. Taken together, the use of a multilevel approach considering events as nested observations in these types of data is advocated as it is more valid and provides more information than other (traditional) methods.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Multilevel analyses of on-demand medication data, with an application to the treatment of Female Sexual Interest/Arousal Disorder (vol 14, e0221063, 2019)
    Kessels, R.
    Bloemers, J.
    Tuiten, A.
    van der Heijden, P. G. M.
    [J]. PLOS ONE, 2019, 14 (10):
  • [2] On the Definition of Female Sexual Interest/Arousal Disorder
    Rosemary Basson
    [J]. Archives of Sexual Behavior, 2014, 43 : 1225 - 1226
  • [3] On the Definition of Female Sexual Interest/Arousal Disorder
    Basson, Rosemary
    [J]. ARCHIVES OF SEXUAL BEHAVIOR, 2014, 43 (07) : 1225 - 1226
  • [4] Systemic testosterone for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopause
    Ribera Torres, Laura
    Angles-Acedo, Sonia
    Lopez Chardi, Laura
    Mension Coll, Eduard
    Castelo-Branco, Camil
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2024, 40 (01)
  • [5] EFFICACY AND SAFETY OF ON-DEMAND USE OF 2 TREATMENTS DESIGNED FOR DIFFERENT ETIOLOGIES OF FEMALE SEXUAL INTEREST/AROUSAL DISORDER: 3 RANDOMIZED CLINICAL TRIALS
    Tuiten, A.
    van Rooij, K.
    Bloemers, J.
    Eisenegger, C.
    van Honk, J.
    Kessels, R.
    Kingsberg, S.
    Derogatis, L. R.
    de Heede, L.
    Gerritsen, J.
    Koppeschaar, H. P. F.
    Olivier, B.
    Everaerd, W.
    Frijlink, H. W.
    Hohle, D.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2018, 15 (07): : S199 - S200
  • [6] Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials
    Tuiten, Adriaan
    van Rooij, Kim
    Bloemers, Jos
    Eisenegger, Christoph
    van Honk, Jack
    Kessels, Rob
    Kingsberg, Sheryl
    Derogatis, Leonard R.
    de Leede, Leo
    Gerritsen, Jeroen
    Koppeschaar, Hans P. F.
    Olivier, Berend
    Everaerd, Walter
    Frijlink, Henderik W.
    Hohle, Daniel
    de lange, Robert P. J.
    Bocker, Koen B. E.
    Pfaus, James G.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2018, 15 (02): : 201 - 216
  • [7] Diagnosis and Treatment of Female Sexual Arousal Disorder
    Jayne, Christopher
    Gago, Bianca A.
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2009, 52 (04): : 675 - 681
  • [8] A psychobiosocial model for assessment, treatment, and relapse prevention for female sexual interest/arousal disorder
    McCarthy, Barry
    Koman, Candace A.
    Cohn, Danielle
    [J]. SEXUAL AND RELATIONSHIP THERAPY, 2018, 33 (03) : 353 - 363
  • [9] RESPONDER VALUES FOR CLINICAL TRIALS IN FEMALE SEXUAL INTEREST/AROUSAL DISORDER
    Pyke, R.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2017, 14 (06): : E366 - E367
  • [10] Female Sexual Interest/Arousal Disorder: A Diagnosis Out of Thin Air
    Richard Balon
    Anita H. Clayton
    [J]. Archives of Sexual Behavior, 2014, 43 : 1227 - 1229